相似文献
1
The multi-faceted roles of cancer-associated fibroblasts in pancreatic cancer.
Cell Signal. 2025 Mar;127:111584. doi: 10.1016/j.cellsig.2024.111584. Epub 2025 Jan 3.
2
The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Biochem Pharmacol. 2025 Jun;236:116849. doi: 10.1016/j.bcp.2025.116849. Epub 2025 Mar 6.
3
Depicting the cellular complexity of pancreatic adenocarcinoma by Imaging Mass Cytometry: focus on cancer-associated fibroblasts.
Front Immunol. 2024 Nov 7;15:1472433. doi: 10.3389/fimmu.2024.1472433. eCollection 2024.
4
Exploring the role of antigen-presenting cancer-associated fibroblasts and CD74 on the pancreatic ductal adenocarcinoma tumor microenvironment.
Med Oncol. 2024 Nov 25;42(1):15. doi: 10.1007/s12032-024-02564-6.
5
GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
FASEB J. 2018 Mar;32(3):1170-1183. doi: 10.1096/fj.201700834R. Epub 2018 Jan 3.
6
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1147-E1156. doi: 10.1073/pnas.1717802115. Epub 2018 Jan 19.
7
Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
Cancer Genomics Proteomics. 2021 May-Jun;18(3):221-243. doi: 10.21873/cgp.20254.
8
CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment.
J Exp Clin Cancer Res. 2024 Oct 3;43(1):277. doi: 10.1186/s13046-024-03201-w.
9
Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
Cancer Med. 2017 Feb;6(2):463-470. doi: 10.1002/cam4.993. Epub 2017 Jan 18.
10
CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
FASEB J. 2020 Jul;34(7):9405-9418. doi: 10.1096/fj.201902990R. Epub 2020 May 26.
本文引用的文献
1
Barriers and opportunities in pancreatic cancer immunotherapy.
NPJ Precis Oncol. 2024 Sep 12;8(1):199. doi: 10.1038/s41698-024-00681-z.
2
Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions.
Commun Biol. 2024 Apr 9;7(1):430. doi: 10.1038/s42003-024-06087-8.
3
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.
Clin Cancer Res. 2024 May 1;30(9):1859-1877. doi: 10.1158/1078-0432.CCR-23-3841.
4
Stiffness-induced cancer-associated fibroblasts are responsible for immunosuppression in a platelet-derived growth factor ligand-dependent manner.
PNAS Nexus. 2023 Dec 18;2(12):pgad405. doi: 10.1093/pnasnexus/pgad405. eCollection 2023 Dec.
5
Inhibiting stromal Class I HDACs curbs pancreatic cancer progression.
Nat Commun. 2023 Dec 6;14(1):7791. doi: 10.1038/s41467-023-42178-6.
6
A Quick Guide to CAF Subtypes in Pancreatic Cancer.
Cancers (Basel). 2023 May 4;15(9):2614. doi: 10.3390/cancers15092614.
7
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.
Nat Commun. 2023 Feb 13;14(1):797. doi: 10.1038/s41467-023-36296-4.
8
GLI1 interaction with p300 modulates SDF1 expression in cancer-associated fibroblasts to promote pancreatic cancer cells migration.
Biochem J. 2023 Feb 15;480(3):225-241. doi: 10.1042/BCJ20220521.
9
Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors.
Front Immunol. 2022 Nov 21;13:958082. doi: 10.3389/fimmu.2022.958082. eCollection 2022.
10
The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial.
EBioMedicine. 2022 Dec;86:104380. doi: 10.1016/j.ebiom.2022.104380. Epub 2022 Nov 28.
Zotero 插件